Washington Trust Advisors’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-61
Closed -$1.55K 689
2023
Q2
$1.55K Hold
61
﹤0.01% 638
2023
Q1
$2.21K Hold
61
﹤0.01% 716
2022
Q4
$2.42K Hold
61
﹤0.01% 712
2022
Q3
$3K Hold
61
﹤0.01% 830
2022
Q2
$3K Hold
61
﹤0.01% 851
2022
Q1
$4K Buy
61
+23
+61% +$1.66K ﹤0.01% 874
2021
Q4
$3K Buy
+38
New +$3.81K ﹤0.01% 946

Other funds holding NVRO

Washington Trust Advisors's NVRO Position: Q3 2023 in Review

Washington Trust Advisors sold out of NEVRO CORP. (NVRO) in Q3 2023, closing a stake of 61 shares — an estimated $1.55K sold.

Washington Trust Advisors first reported a position in NVRO in Q4 2021 and held it in 7 quarters. The position peaked at $4K in Q1 2022. 136 funds tracked by Wall St. Rank hold NVRO as of Q3 2023.

  • Washington Trust Advisors reported no remaining NEVRO CORP. position as of Q3 2023 after selling out during the quarter.
  • Washington Trust Advisors sold 61 NEVRO CORP. shares in Q3 2023, an estimated $1.55K.
  • Washington Trust Advisors first reported a position in NEVRO CORP. in Q4 2021 and held it in 7 quarters.
  • Washington Trust Advisors's NEVRO CORP. position peaked at $4K in Q1 2022.
  • 136 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2023.

Based on Washington Trust Advisors's 13F filing for Q3 2023, filed 18 Oct 2023.